about
The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and GlycineFrom unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsyAdenosine kinase: exploitation for therapeutic gain.What non-neuronal mechanisms should be studied to understand epileptic seizures?Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsyRole of adenosine in status epilepticus: a potential new target?Homeostasis or channelopathy? Acquired cell type-specific ion channel changes in temporal lobe epilepsy and their antiepileptic potentialNeurochemical measurement of adenosine in discrete brain regions of five strains of inbred miceAdenosine receptors as drug targets--what are the challenges?Effects of coffee/caffeine on brain health and disease: What should I tell my patients?Neuronal transgene expression in dominant-negative SNARE miceCandidate drug targets for prevention or modification of epilepsyGenetic variation in the adenosine regulatory cycle is associated with posttraumatic epilepsy developmentComorbidities in Neurology: Is adenosine the common link?Extracellular ATP induces graded reactive response of astrocytes and strengthens their antioxidative defense in vitro.Glycine transporter 1 is a target for the treatment of epilepsy.Adenosinergic signaling in epilepsyPurines: forgotten mediators in traumatic brain injury.Upregulation of adenosine kinase in Rasmussen encephalitis.Overexpression of adenosine kinase in cortical astrocytes and focal neocortical epilepsy in miceIdentification of altered brain metabolites associated with TNAP activity in a mouse model of hypophosphatasia using untargeted NMR-based metabolomics analysis.Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?Moonlighting adenosine deaminase: a target protein for drug development.Presynaptic mechanisms of neuronal plasticity and their role in epilepsy.The role of glia in stress: polyamines and brain disordersPotential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging.How does adenosine control neuronal dysfunction and neurodegeneration?Ethanol Tolerance Affects Endogenous Adenosine Signaling in Mouse Hippocampus.Differential Expression of Adenosine P1 Receptor ADORA1 and ADORA2A Associated with Glioma Development and Tumor-Associated Epilepsy.Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies.Adenosine kinase deficiency: expanding the clinical spectrum and evaluating therapeutic options.Purines released from astrocytes inhibit excitatory synaptic transmission in the ventral horn of the spinal cord.Chronic sleep restriction induces long-lasting changes in adenosine and noradrenaline receptor density in the rat brain.A scaffold as a platform for new therapies?A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.Presynaptic adenosine A₁ receptors modulate excitatory transmission in the rat basolateral amygdalaKetogenic diet prevents epileptogenesis and disease progression in adult mice and rats.Targeting ENT1 and adenosine tone for the treatment of Huntington's disease.Stable Knockdown of Adenosine Kinase by Lentiviral Anti-ADK miR-shRNAs in Wharton's Jelly Stem Cells.Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy.
P2860
Q26752724-AB8228FC-A674-48BB-8BC4-C967CCEAA6E4Q26770025-74277744-3FD7-408F-A458-07103F68FEF4Q26852056-DBAAE269-2D56-4042-A067-03AA658A62BEQ26853726-481B852D-0240-4D07-8EAA-B9A86523ECECQ26859135-371EC23A-9573-45C8-94D2-852B6824F31DQ26991984-60F7DBF8-BD7F-4ADB-AE6D-328B18041979Q28080655-8A798D66-EC77-4E68-9EC2-1947DF9998C5Q28541087-2A21E332-52CF-43AD-9140-3E22965EBDABQ29346491-E3CF5226-39B1-43B9-BCF3-CF65CFDE70C9Q34505480-49440A1C-051F-4BBE-AAEC-CD5077D546A6Q34664201-F45B9AB0-E739-4898-A4BA-5D44E22260BAQ35594944-E49FDCA1-24AD-4383-902C-6B01388A37BBQ35911926-431B4DF9-9A2A-44DC-BBD1-225B8F49C66DQ35956389-E28B0B9A-6C34-423C-9523-36045CCA471AQ36156190-B598AFF1-9273-456D-9590-43279A7D8B24Q36304849-19875A4B-B3B8-4E7E-BC44-47852F6603A3Q36643060-8D7B900C-E2A7-44C0-91B6-B0DEC130637CQ36788533-AFDD83ED-85F6-4960-A80D-054A63A0A74FQ37272771-57400C18-8072-46A0-947C-80D0DB639509Q37619427-8957417F-83F7-4B66-8A9A-90FF1D9D8A5BQ37682966-DEA8F324-794D-4ECA-A56F-4B2B3360935DQ38134724-7716EBD7-DCC6-4076-93B8-7C9F82A6D220Q38220597-6564717A-C7E4-4F74-A8FD-1F4EACA21DDDQ38225535-94F97215-3857-4DDD-8231-9C739203881AQ38278661-31674B52-F2D7-4F52-92B2-43D805B27AEDQ38765118-ACFAE29E-E5CC-48EB-84AD-6E2A29C404DFQ38882782-122BE3CA-CAEC-4767-87D8-285AF960ADA9Q39758330-6A3E8287-04C3-497E-87BC-65D9CE407E0DQ39868877-C88DACD5-28D1-4BB2-8E41-C2D27840A67DQ40201379-97EBD6FA-487D-426F-81EE-23F1B2341013Q40237006-34938BA5-C19B-4C7E-9C76-947892681D35Q40294709-2E631283-43AC-4B01-96BC-EE546CBA8E0FQ41032052-870712A7-2F69-428F-8006-9F913F09E805Q41676620-BF482076-D238-4939-885A-DF993AFDAEB1Q41755392-B670C1F6-5406-4545-9F88-BC9794BCB6D9Q42448328-BF2E2F4A-EC44-4CEA-9448-0CEC653AAB28Q43161211-AE9B2229-F599-4240-BECF-EB7668342078Q45299960-EDBD5EEA-7BED-4DCA-A938-16C44A7F696FQ47225613-8DAC36C8-3309-40D6-8B7D-61A013A0DDCEQ47416325-98F65CE5-FCF8-42C5-BF77-58F3C36BBC66
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Adenosine dysfunction in epilepsy.
@ast
Adenosine dysfunction in epilepsy.
@en
type
label
Adenosine dysfunction in epilepsy.
@ast
Adenosine dysfunction in epilepsy.
@en
prefLabel
Adenosine dysfunction in epilepsy.
@ast
Adenosine dysfunction in epilepsy.
@en
P2860
P356
P1433
P1476
Adenosine dysfunction in epilepsy.
@en
P2860
P304
P356
10.1002/GLIA.22285
P577
2011-12-22T00:00:00Z